Today’s Analyst Moves: Thermo Fisher Scientific Inc. (TMO), Brown & Brown Inc. (BRO)

You should consider shares of Thermo Fisher Scientific Inc. (NYSE:TMO) and Brown & Brown Inc. (NYSE:BRO) if you are looking for a great stocks to invest in. Starting with the TMO shares, which traded at $335.20 at the close of the recent session, gaining 0.72%. On Wednesday, the company’s shares shed $2.4 from its value which represented in intraday trading. The stock is now 3.18% higher in year-to-date (YTD) trading. TMO’s intraday high was $336.89 while its lowest price touched $333.00. The stock’s 52-week high price is $335.09, which means the current price is at 0.03%. In terms of trading activity, the daily trading volume fell to 1289509 against 200-day average trading volume of 1,423,204 shares.

What are analyst forecasts for Thermo Fisher Scientific Inc. (NYSE:TMO)?

At a consensus rating of 4.62, TMO is trending as a streaking Strong Buy, as it has been the case a month ago when 11 analysts called it a Strong Buy. Two months ago, 11 analysts recommended, on average, that TMO stock is a Strong Buy. The Healthcare company’s shares’ overall bullish trend saw it close lower on Wednesday compared to its opening price of $333.00 on the day.

Forecasts for Thermo Fisher Scientific Inc. (NYSE:TMO) give the stock a fair value for the growth of 4.23% from its last price. The 12-month price forecast for the stock by analysts puts the stock’s mean price target at $350.00, which means the price per share could rise by nearly $14.8. The price range target is between a low of $314.00 and a high of $380.00. The stock would need to gain by about $11.79 to hit the estimated high or 0.7% from its 12-month low.

The consensus among 17 analysts is that it is a good time for one to Buy in the Thermo Fisher Scientific Inc. 15 analysts rate TMO as a Buy, with 0 of 17 analysts rate it as a Sell. 1 have valued the stock as Overweight and 1 have recommended that investors Hold.

Thermo Fisher Scientific Inc. (NYSE:TMO) Upgrades and Downgrades

In terms of rating changes, Wells Fargo on January 08, 2020, Initiated Thermo Fisher Scientific Inc. (TMO) at Equal Weight. They believe the stock could reach $350 in the near term. Analysts at Citigroup have assigned a Buy rating for the stock in their research note on January 07, 2020 with an estimated price target of $380. Moreover, Stifel analysts issued a rating of Buy for the stock on November 15, 2019. On July 25, 2019, the stock earned a Buy rating due to an analyst call from Needham, while analysts from Needham on July 16, 2019 suggested that the stock is Buy.

Brown & Brown Inc. (NYSE:BRO) adds $0.38 on Wednesday

The BRO stock has risen 2.81% year-to-date and is currently trading at $40.59, which is -0.25% below its 52-week high. The company shares gained 0.95% on the day and have risen nearly 54.75% off a low hit. At current levels, Brown & Brown Inc. has a valuation of about $2.32B. As of 01/15/20, this stock has risen 2.01% during the week and closed at $40.21 in the previous session. However, recent Brown & Brown Inc. stock performance shows that BRO shares are 4.45% up over the last month, and 12.66% up for the last three months.

Earnings per share (EPS) estimates for the current quarter are $0.27, with the trailing 12-month share earnings at $1.39. The ratio is expected to be up by 13.00% for the current year 2019 and 9.40% for next year. Over the next 5-year period, earnings per share will be 10.35%. But will the BRO stock surprise in the current quarter results, where the $0.39 actual EPS reported on 9/29/2019 surprised by 2.60% or was higher by $0.01 from the estimated $0.38.

Sales Growth to climb 6.70% for the year

How well will Brown & Brown Inc. perform as a business over the current quarter, year and next 5-year period? Compared to the year-ago quarter, analysts forecast the company to bring in between $555.4M and $570.67M in current quarter sales. The consensus estimated for the current quarter is $563.56M from sales. Forecasts for this fiscal year are between $2.37B and $2.39B and the consensus estimate for sales is at $2.38B. BRO has its next quarter sales estimates at between $644.04M and $691.22M, with the quarter-over-quarter growth estimates at 11.30% and the annual growth forecast for the year at 6.70%.

Who owns shares in Brown & Brown Inc. (BRO)?

Let’s briefly focus on the share ownership of the Brown & Brown Inc. (NYSE:BRO) stock, where we find that 7.65% of shares are held by institutions. Vanguard Group, Inc. (The) tops the list of institutional owners as it is holding 25.23 million shares or 8.97% of shares outstanding. Blackrock Inc. and Wells Fargo & Company held 22.01 million and 12.05 million representing 7.83% and 4.28% respectively at the close of the last trading session. As of Sep 29, 2019, First Eagle Investment Management, LLC accounted for 10.04 million shares at over 362.13 million. This represented 3.57% of shares outstanding. Select Equity Group, Inc. held 9.88 million shares at over 356.16 million representing 3.51% of shares outstanding.

BRO Insider Activity

Insider activity can also give a signal in terms of price direction. Looking at Brown & Brown Inc. (BRO), a total of 30000 shares have been sold by insiders over the last 6 months while 5000 shares were added in the same time span. On 12/19/2019, by the name Penny Jerome Scott sold 30000.0 shares worth $1.2 million at the price of $39.47 per share. Filings also show that Strianese Anthony T sold a total of 35000.0 shares on 3/13/2019 valued at $1000000.0. Since the last insider activity, the company’s share price has climbed 39.15%.